BIOENTROPY harnesses the predictive prowess of AGHI, alongside advanced scientific tools like 4D atomic imaging and precise gene and protein editing, to deeply delve into innovative therapeutic designs. This approach aims to address critical medical challenges that have eluded traditional drug discovery methods.
Bioentropy is committed to combating CNS (Central Nervous System) diseases, specifically neurodegenerative conditions and neuroinflammation. Empowered by AGHI, our innovative approach to harnessing innate immunity and protein editing establishes a distinct drug discovery pipeline, targeting diseases that currently lack specific treatments or cures.
© 2024 Bioentropy Inc. All rights reserved.